suministro del principio activo denominado " AVAPRITINIB 100 MGCOMPRIMIDO ORAL " para el Hospital Universitario de Gran Canaria Dr. Negrín.
Buyer
NameDirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
CountryES
Published2026-09-18
Deadline—
Value
Estimated—
Awarded€83,973 · 83,972.7 EUR
WinnerBLUEPRINT MEDICINES (NETHERLANDS)
Who already wins at this buyer
Firms with recorded awards from Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| AMGEN, S.A | 2 | €198,635 | 2026-08-12 |
| IPSEN PHARMA, S.A.U. | 1 | €595,637 | 2026-06-18 |
| SWEDISH ORPHAN BIOVITRUM S.L | 1 | €403,705 | 2026-05-27 |
| IPSEN PHARMA, S.A. | 1 | €396,028 | 2026-05-11 |
| MERCK SHARP & DOHME ESPAÑA, S.A. | 1 | €332,277 | 2026-05-11 |
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
El objeto del contrato viene determinado por el suministro del principio activo denominado "AVAPRITINIB 100MG COMPRIMIDO ORAL" para el Hospital Universitario de Gran Canaria Dr. Negrín.Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura VocabularioComún de Contratos (CPV) de la Comisión Europea.
Similar tenders
Closest by meaning — across languages, via embeddings.